Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

31 Dec 2014

Abstract excerpt

Juvenile myelomonocytic leukemia is a rare myeloproliferative disease in young children. While hematopoietic stem cell transplantation remains the only curative therapeutic option for most patients, children with juvenile myelomonocytic leukemia increasingly receive novel agents in phase I-II clinical trials as pre-transplant therapy or therapy for relapse after transplantation. However, response criteria or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Histone Deacetylase Inhibitors Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25552679
DOI: 10.3324/haematol.2014.109892

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemiaPMID 25552679Read ↗

Diagnosis and treatment of juvenile myelomonocytic leukemiaSemantic proximity Read ↗

Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.Semantic proximity Read ↗

Molecular basis of juvenile myelomonocytic leukemiaSemantic proximity Read ↗

Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell TransplantationSemantic proximity Read ↗

[Juvenile myelomonocytic leukemia (JMML): recent advances in molecular pathogenesis and treatment].Semantic proximity Read ↗

[Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML)].Semantic proximity Read ↗

[Molecular mechanism and progress in treatment of juvenile myelomonocytic leukemia (JMML)].Semantic proximity Read ↗

A reduced-toxicity myeloablative conditioning approach for hematopoietic cell transplant in juvenile myelomonocytic leukemiaSemantic proximity Read ↗

Juvenile Myelomonocytic LeukemiaSemantic proximity Read ↗

Juvenile Myelomonocytic LeukemiaSemantic proximity Read ↗

Current Treatment of Juvenile Myelomonocytic LeukemiaSemantic proximity Read ↗

Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.